Mesothelioma Patients Encouraged by Results of Tumor Treating Fields Study

Tumor treating fields are one of the most promising innovations being offered to patients with malignant mesothelioma. The protocol uses electrical fields to kill cancer cells and was only recently approved for use in treating the rare asbestos-related disease. A study examining tumor treating fields’ effectiveness in treating patients with a different type of cancer

Puerto Rico Mesothelioma Lawyer

Puerto Rico mesothelioma lawyers help residents of the island file lawsuits and get the best care for this rare type of cancer. Several sites in Puerto Rico exposed people to asbestos in the past, leading many to develop mesothelioma or lung cancer. Many residents and workers in the territory are still at risk of asbestos

Judge Denies Goodyear’s Petition to Have Asbestos Case Against them Dismissed

Though malignant mesothelioma is the deadliest asbestos-related disease, it is far from the only one. Asbestosis, asbestos-related lung cancer, COPD, and many other malignancies have been attributed to inhalation or ingestion of the carcinogen. Paul M. Moutal blames his lung cancer on exposure to asbestos in Goodyear floor tiles that he cut and installed during

Italian Study Examines Mesothelioma Rate Advancement Among Asbestos Cement Workers

It is well known that exposure to asbestos causes malignant mesothelioma. What is not as understood is the degree to which exposure to significant levels of asbestos expedites the disease’s occurrence. Italian researchers conducted a study to answer this question, looking at victims of both malignant pleural mesothelioma and asbestos-related lung cancer.

Refinery Workers with Mesothelioma Seek Compensation from Hess 

Seeking shelter from hundreds of asbestos exposure lawsuits filed by victims of mesothelioma, asbestos-related lung cancer, and other serious illnesses, Hess Corporation has put a subsidiary company into bankruptcy protection. In response, those victims are now redirecting their legal actions to the parent company itself.

Penn Study Finds Immunotherapy Superior to Chemotherapy as Second-Line Treatment 

The challenges of treating malignant mesothelioma are undeniable: those diagnosed with the rare and deadly form of cancer are immediately told that their condition is terminal. Still, many patients are extending their survival time by taking advantage of innovative treatment options. A recent study by researchers at the University of Pennsylvania made clear that immunotherapy

New Genetic Test May Guide Selection of Mesothelioma Treatment

Mesothelioma is one of the most challenging forms of cancer to treat. The rare, asbestos-related disease is notoriously resistant to traditional treatments, leaving few options and short survival times for its victims. But the results of a new study conducted on lung cancer patients may point to a powerful new method of selecting the best

Get Help Contacting Mesothelioma.net
This field is for validation purposes and should be left unchanged.
24/7 Live Chat
Online Now